|
|
| | 1H-Pyrazole-4-carboxamide, 1-[(3R,4S)-4-cyanotetrahydro-2H-pyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridinyl)amino]- Basic information |
| | 1H-Pyrazole-4-carboxamide, 1-[(3R,4S)-4-cyanotetrahydro-2H-pyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridinyl)amino]- Chemical Properties |
| Boiling point | 623.6±55.0 °C(Predicted) | | density | 1.53±0.1 g/cm3(Predicted) | | pka | 14.99±0.50(Predicted) | | form | Solid | | color | White to off-white |
| | 1H-Pyrazole-4-carboxamide, 1-[(3R,4S)-4-cyanotetrahydro-2H-pyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridinyl)amino]- Usage And Synthesis |
| Uses | Atinvicitinib is a kind of pyrazole compound. Atinvicitinib has the potential for the research of atopic dermatitis (extracted from patent WO2021123094A1)[1]. | | References | [1] Mohamad Morsey, et al. Bispecific caninized antibodies and bispecific binding partners for treating atopic dermatitis. Patent WO2021123094A1. |
| | 1H-Pyrazole-4-carboxamide, 1-[(3R,4S)-4-cyanotetrahydro-2H-pyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridinyl)amino]- Preparation Products And Raw materials |
|